Water-soluble fullerene (C60) inhibits the osteoclast differentiation and bone destruction in arthritis
Authors:
Open Access
- 1 October 2009
- journal article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 4, 233-9
Abstract
Peer reviewed article authored by (Kazuo Yudoh, Rie Karasawa, Kayo Masuko, et al). Read article or submit your manuscript for publishing.Keywords
This publication has 24 references indexed in Scilit:
- Dendritic Cells at the Osteo-Immune Interface: Implications for Inflammation-Induced Bone LossJournal of Bone and Mineral Research, 2007
- Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant‐induced arthritisArthritis & Rheumatism, 2007
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- Osteoclasts, rheumatoid arthritis, and osteoimmunologyCurrent Opinion in Rheumatology, 2006
- Antioxidant α-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-κB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-κB ligand and tumor necrosis factor-αFree Radical Biology and Medicine, 2006
- [60]Fullerene is a Powerful Antioxidant in Vivo with No Acute or Subacute ToxicityNano Letters, 2005
- ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunityNature Immunology, 2005
- Characterisation of cytosolic FK506 binding protein 12 and its role in modulating expression of Cbfa1 and osterix in ROS 17/2.8 cellsBone, 2005
- Reactive oxygen species mediate RANK signaling in osteoclastsExperimental Cell Research, 2004
- A Novel Promoting Action of Fullerene C60 on the Chondrogenesis in Rat Embryonic Limb Bud Cell Culture SystemBiochemical and Biophysical Research Communications, 1995